{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:17:39Z","timestamp":1781921859989,"version":"3.54.5"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100012665","name":"Institute for Clinical Evaluative Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009142","name":"Cancer Care Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004726","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,14]]},"abstract":"<jats:p>Despite similar stage at presentation and rates of cancer treatment, patients under 65 with inflammatory bowel disease associated colorectal cancer have worse survival outcomes than patients under 65 with sporadic colorectal cancer. This difference diminishes over age 65.<\/jats:p>","DOI":"10.1093\/ibd\/izz088","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T06:45:35Z","timestamp":1557297935000},"page":"1957-1965","source":"Crossref","is-referenced-by-count":37,"title":["Age-Related Survival Differences in Patients With Inflammatory Bowel Disease\u2013Associated Colorectal Cancer: A Population-Based Cohort Study"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5536-1530","authenticated-orcid":false,"given":"Jessica","family":"Bogach","sequence":"first","affiliation":[{"name":"Departments of Surgery, Hamilton, ON, Canada"},{"name":"Departments of Health Research Methods, Evidence and Impact, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Pond","sequence":"additional","affiliation":[{"name":"Departments of Health Research Methods, Evidence and Impact, Hamilton, ON, Canada"},{"name":"Departments of Oncology, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagla","family":"Eskicioglu","sequence":"additional","affiliation":[{"name":"Departments of Surgery, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien","family":"Seow","sequence":"additional","affiliation":[{"name":"Departments of Health Research Methods, Evidence and Impact, Hamilton, ON, Canada"},{"name":"Departments of Oncology, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"2019111410284447300_CIT0001","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1158\/1940-6207.CAPR-16-0124","article-title":"Colorectal cancer and dysplasia in inflammatory bowel disease: a review of disease epidemiology, pathophysiology, and management","volume":"9","author":"Dulai","year":"2016","journal-title":"Cancer Prev Res"},{"key":"2019111410284447300_CIT0002","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut."},{"key":"2019111410284447300_CIT0003","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/gut.35.5.651","article-title":"Crohn\u2019s disease and colorectal cancer","volume":"35","author":"Gillen","year":"1994","journal-title":"Gut."},{"key":"2019111410284447300_CIT0004","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1136\/gut.35.11.1590","article-title":"Ulcerative colitis and Crohn\u2019s disease: a comparison of the colorectal cancer risk in extensive colitis","volume":"35","author":"Gillen","year":"1994","journal-title":"Gut."},{"key":"2019111410284447300_CIT0005","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies","volume":"19","author":"Lutgens","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"2019111410284447300_CIT0006","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.3748\/wjg.v20.i29.9872","article-title":"Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis","volume":"20","author":"Kim","year":"2014","journal-title":"World J Gastroenterol."},{"key":"2019111410284447300_CIT0007","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/jso.21505","article-title":"Ulcerative colitis and cancer","volume":"101","author":"Kulaylat","year":"2010","journal-title":"J Surg Oncol."},{"key":"2019111410284447300_CIT0008","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","article-title":"Intestinal inflammation and cancer","volume":"140","author":"Ullman","year":"2011","journal-title":"Gastroenterology."},{"key":"2019111410284447300_CIT0009","first-page":"3137","article-title":"High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer","volume":"33","author":"Elzagheid","year":"2013","journal-title":"Anticancer Res."},{"key":"2019111410284447300_CIT0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.pharmtox.42.082301.164620","article-title":"COX-2: a target for colon cancer prevention","volume":"42","author":"Marnett","year":"2002","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"2019111410284447300_CIT0011","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ajg.2011.50","article-title":"5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study","volume":"106","author":"Bernstein","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"2019111410284447300_CIT0012","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1572-0241.2005.41442.x","article-title":"Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies","volume":"100","author":"Velayos","year":"2005","journal-title":"Am J Gastroenterol."},{"key":"2019111410284447300_CIT0013","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1155\/2001\/934734","article-title":"Colorectal cancer complicating Crohn\u2019s disease","volume":"15","author":"Freeman","year":"2001","journal-title":"Can J Gastroenterol."},{"key":"2019111410284447300_CIT0014","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s11605-013-2171-z","article-title":"Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis","volume":"17","author":"Renz","year":"2013","journal-title":"J Gastrointest Surg."},{"key":"2019111410284447300_CIT0015","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/j.clcc.2016.09.005","article-title":"Chemotherapy tolerance and oncologic outcomes in patients with colorectal cancer with and without inflammatory bowel disease","volume":"16","author":"Axelrad","year":"2017","journal-title":"Clin Colorectal Cancer."},{"key":"2019111410284447300_CIT0016","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/ibd.21053","article-title":"Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer","volume":"16","author":"Brackmann","year":"2010","journal-title":"Inflamm Bowel Dis."},{"key":"2019111410284447300_CIT0017","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00384-017-2754-3","article-title":"A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer","volume":"32","author":"Reynolds","year":"2017","journal-title":"Int J Colorectal Dis."},{"key":"2019111410284447300_CIT0018","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/DCR.0b013e318242620f","article-title":"Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study","volume":"55","author":"Gearhart","year":"2012","journal-title":"Dis Colon Rectum."},{"key":"2019111410284447300_CIT0019","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/cncr.30642","article-title":"Immune checkpoint inhibitors in challenging populations","volume":"123","author":"Johnson","year":"2017","journal-title":"Cancer."},{"key":"2019111410284447300_CIT0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jamaoncol.2015.4368","article-title":"Ipilimumab therapy in patients with advanced melanoma and preexisting autoimmune disorders","volume":"2","author":"Johnson","year":"2016","journal-title":"JAMA Oncol."},{"key":"2019111410284447300_CIT0021","volume-title":"Ontario\u2019s Health System: Key Insights for Engaged Citizens, Professionals and Policymakers","author":"Lavis","year":"2016"},{"key":"2019111410284447300_CIT0022","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/gut.2009.188383","article-title":"Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data","volume":"58","author":"Benchimol","year":"2009","journal-title":"Gut."},{"key":"2019111410284447300_CIT0023","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jclinepi.2014.02.019","article-title":"Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada","volume":"67","author":"Benchimol","year":"2014","journal-title":"J Clin Epidemiol."},{"key":"2019111410284447300_CIT0024","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol."},{"key":"2019111410284447300_CIT0025","volume-title":"AJCC Cancer Staging Manual.","author":"Edge","year":"2010","edition":"7th ed"},{"key":"2019111410284447300_CIT0026","volume-title":"Colon cancer","author":"Network","year":"2017"},{"key":"2019111410284447300_CIT0027","volume-title":"Guidelines on Person Level Costing Using Administrative Databases in Ontario. Working Paper Series.","author":"Wodchis","year":"2013"},{"key":"2019111410284447300_CIT0028","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.3748\/wjg.v18.i29.3839","article-title":"Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?","volume":"18","author":"Dyson","year":"2012","journal-title":"World J Gastroenterol."},{"key":"2019111410284447300_CIT0029","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cgh.2005.12.035","article-title":"Colorectal cancer prognosis among patients with inflammatory bowel disease","volume":"4","author":"Delaunoit","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2019111410284447300_CIT0030","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.crohns.2014.05.006","article-title":"Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature","volume":"8","author":"Duricova","year":"2014","journal-title":"J Crohns Colitis."},{"key":"2019111410284447300_CIT0031","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ibd.20542","article-title":"Two distinct groups of colorectal cancer in inflammatory bowel disease","volume":"15","author":"Brackmann","year":"2009","journal-title":"Inflamm Bowel Dis."},{"key":"2019111410284447300_CIT0032","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2036.2006.03132.x","article-title":"Long-term prognosis in Crohn\u2019s disease: an epidemiological study of patients diagnosed more than 20 years ago in Cardiff","volume":"25","author":"Canavan","year":"2007","journal-title":"Aliment Pharmacol Ther."},{"key":"2019111410284447300_CIT0033","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1053\/j.gastro.2003.09.036","article-title":"Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County","volume":"125","author":"Winther","year":"2003","journal-title":"Gastroenterology."},{"key":"2019111410284447300_CIT0034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cgh.2012.09.026","article-title":"Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010","volume":"11","author":"Jess","year":"2013","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2019111410284447300_CIT0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/2229-3485.179436","article-title":"Common pitfalls in statistical analysis: the perils of multiple testing","volume":"7","author":"Ranganathan","year":"2016","journal-title":"Perspect Clin Res."},{"key":"2019111410284447300_CIT0036","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What\u2019s wrong with Bonferroni adjustments","volume":"316","author":"Perneger","year":"1998","journal-title":"BMJ."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/25\/12\/1957\/30746071\/izz088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/25\/12\/1957\/30746071\/izz088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T10:29:03Z","timestamp":1573727343000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/25\/12\/1957\/5486981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,5,8]]},"published-print":{"date-parts":[[2019,11,14]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izz088","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,5,8]]}}}